Theravance Biopharma Inc. (TBPH) tumbled -6.07% or -1.6 to $24.66. It is approximately 66122 shares traded, which is 33.12% compare to the average total volume 199645. The market cap of TBPH is $1.37 billion. The year to date change is -5.77%. The 52 week price range is from $21.27 to $35.48. Price of TBPH have changed -1.17% during last week. It have changed 12.08% over last month, 6.36% over last 3 months, 12.61% over last 6 months and -7.40% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for TBPH is 26.24. It is 6.41% above current price. The 200-day Moving Averages for TBPH is 26.15. It is 6.04% above current price. The 52-week High is 35.48. It is 43.88% from the current price. The 52-week Low is 21.27. It is -13.75% from current price.
There are some statistics of TBPH. It is has market cap $1.37 billion. The share outstanding is 55.41 million. The average volume is 199645. The percent of top 15 Institution holding is 145.00%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of TBPH is -295.61%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of TBPH is -58.86%.